BioLife Capital Stock from 2010 to 2025

BLFS Stock

USD 26.01 1.02 4.08%

BioLife Solutions Capital Stock yearly trend continues to be comparatively stable with very little volatility. Capital Stock will likely drop to about 39.3 K in 2025. Capital Stock is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. View All Fundamentals

Capital Stock

First Reported

2010-12-31

Previous Quarter

47 K

Current Value

39.3 K

Quarterly Volatility

11.5 K

Credit Downgrade

Yuan Drop

Covid

Check BioLife Solutions financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioLife Solutions' main balance sheet or income statement drivers, such as Interest Expense of 755 K, Selling General Administrative of 38.5 M or Total Revenue of 86.4 M, as well as many indicators such as Price To Sales Ratio of 13.81, Dividend Yield of 0.0014 or PTB Ratio of 3.26. BioLife financial statements analysis is a perfect complement when working with BioLife Solutions Valuation or Volatility modules.

Check out the analysis of BioLife Solutions Correlation against competitors.

For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.

Latest BioLife Solutions' Capital Stock Growth Pattern

Below is the plot of the Capital Stock of BioLife Solutions over the last few years. It is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. BioLife Solutions' Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioLife Solutions' overall financial position and show how it may be relating to other accounts over time.

Capital Stock

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Capital Stock

Timeline

BioLife Capital Stock Regression Statistics

	Arithmetic Mean	27,580
	Geometric Mean	25,578
	Coefficient Of Variation	41.85
	Mean Deviation	10,475
	Median	19,000
	Standard Deviation	11,543
	Sample Variance	133.2M
	Range	28K
	R-Value	0.85
	Mean Square Error	38.7M
	R-Squared	0.73
	Significance	0.000026
	Slope	2,070
	Total Sum of Squares	2B

BioLife Capital Stock History

	2025	39.3 K
	2024	47 K
	2023	45 K
	2022	43 K
	2021	42 K
	2020	33 K
	2019	21 K

BioLife Solutions Capital Stock component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Total Liab	Total Current Assets	Accounts Payable	Net Receivables	Short Term Investments	Short Term Debt	Common Stock	Current Deferred Revenue	Intangible Assets	Property Plant Equipment	Long Term Debt	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Accumulated Depreciation	Long Term Debt Total	Long Term Investments	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.63	-0.45	-0.79	0.95	0.96	0.81	0.87	0.53	0.81	0.37	0.48	0.67	0.97	0.5	0.98	0.94	0.89	-0.6	-0.44	0.73	0.44	0.99	0.91	0.97
Total Stockholder Equity	0.63		-0.71	-0.5	0.45	0.62	0.23	0.21	-0.26	0.58	0.22	0.29	0.56	0.64	-0.1	0.68	0.65	0.62	-0.4	-0.5	0.37	0.51	0.61	0.57	0.61
Net Debt	-0.45	-0.71		0.36	-0.19	-0.6	-0.02	-0.04	0.19	-0.37	-0.05	-0.23	-0.33	-0.49	0.39	-0.52	-0.63	-0.54	0.44	0.59	-0.49	-0.39	-0.41	-0.62	-0.45
Retained Earnings	-0.79	-0.5	0.36		-0.78	-0.85	-0.42	-0.6	-0.56	-0.93	-0.34	-0.09	-0.11	-0.89	-0.53	-0.83	-0.85	-0.79	0.54	0.66	-0.66	-0.78	-0.75	-0.77	-0.87
Total Liab	0.95	0.45	-0.19	-0.78		0.88	0.85	0.92	0.66	0.79	0.46	0.45	0.56	0.92	0.75	0.92	0.85	0.8	-0.47	-0.31	0.69	0.39	0.95	0.84	0.94
Total Current Assets	0.96	0.62	-0.6	-0.85	0.88		0.67	0.77	0.54	0.83	0.35	0.43	0.5	0.97	0.43	0.97	0.99	0.91	-0.64	-0.56	0.83	0.53	0.93	0.96	0.96
Accounts Payable	0.81	0.23	-0.02	-0.42	0.85	0.67		0.96	0.65	0.44	0.28	0.62	0.77	0.68	0.59	0.73	0.64	0.63	-0.48	0.07	0.55	-0.08	0.85	0.66	0.73
Net Receivables	0.87	0.21	-0.04	-0.6	0.92	0.77	0.96		0.79	0.57	0.3	0.56	0.62	0.78	0.69	0.79	0.74	0.71	-0.52	-0.07	0.67	0.09	0.88	0.74	0.82
Short Term Investments	0.53	-0.26	0.19	-0.56	0.66	0.54	0.65	0.79		0.42	0.18	0.29	0.07	0.52	0.7	0.47	0.5	0.48	-0.39	-0.02	0.61	0.09	0.54	0.53	0.56
Short Term Debt	0.81	0.58	-0.37	-0.93	0.79	0.83	0.44	0.57	0.42		0.41	0.01	0.23	0.91	0.53	0.87	0.8	0.71	-0.36	-0.73	0.55	0.85	0.77	0.73	0.86
Common Stock	0.37	0.22	-0.05	-0.34	0.46	0.35	0.28	0.3	0.18	0.41		-0.18	0.16	0.39	0.51	0.38	0.31	0.31	0.2	-0.18	0.27	0.3	0.4	0.38	0.42
Current Deferred Revenue	0.48	0.29	-0.23	-0.09	0.45	0.43	0.62	0.56	0.29	0.01	-0.18		0.62	0.34	0.11	0.4	0.46	0.43	-0.59	0.34	0.45	-0.38	0.52	0.5	0.42
Intangible Assets	0.67	0.56	-0.33	-0.11	0.56	0.5	0.77	0.62	0.07	0.23	0.16	0.62		0.49	0.11	0.61	0.5	0.49	-0.42	0.04	0.37	-0.18	0.69	0.5	0.5
Property Plant Equipment	0.97	0.64	-0.49	-0.89	0.92	0.97	0.68	0.78	0.52	0.91	0.39	0.34	0.49		0.5	0.99	0.96	0.89	-0.55	-0.6	0.72	0.62	0.95	0.91	0.98
Long Term Debt	0.5	-0.1	0.39	-0.53	0.75	0.43	0.59	0.69	0.7	0.53	0.51	0.11	0.11	0.5		0.46	0.36	0.35	-0.03	-0.04	0.39	0.23	0.52	0.38	0.54
Net Tangible Assets	0.98	0.68	-0.52	-0.83	0.92	0.97	0.73	0.79	0.47	0.87	0.38	0.4	0.61	0.99	0.46		0.95	0.85	-0.57	-0.54	0.73	0.54	0.97	0.91	0.97
Capital Surpluse	0.94	0.65	-0.63	-0.85	0.85	0.99	0.64	0.74	0.5	0.8	0.31	0.46	0.5	0.96	0.36	0.95		0.94	-0.69	-0.56	0.8	0.51	0.91	0.95	0.95
Deferred Long Term Liab	0.89	0.62	-0.54	-0.79	0.8	0.91	0.63	0.71	0.48	0.71	0.31	0.43	0.49	0.89	0.35	0.85	0.94		-0.65	-0.5	0.68	0.44	0.84	0.87	0.88
Accumulated Depreciation	-0.6	-0.4	0.44	0.54	-0.47	-0.64	-0.48	-0.52	-0.39	-0.36	0.2	-0.59	-0.42	-0.55	-0.03	-0.57	-0.69	-0.65		0.21	-0.61	-0.05	-0.57	-0.61	-0.56
Long Term Debt Total	-0.44	-0.5	0.59	0.66	-0.31	-0.56	0.07	-0.07	-0.02	-0.73	-0.18	0.34	0.04	-0.6	-0.04	-0.54	-0.56	-0.5	0.21		-0.3	-0.85	-0.33	-0.41	-0.45
Long Term Investments	0.73	0.37	-0.49	-0.66	0.69	0.83	0.55	0.67	0.61	0.55	0.27	0.45	0.37	0.72	0.39	0.73	0.8	0.68	-0.61	-0.3		0.28	0.74	0.86	0.75
Short Long Term Debt	0.44	0.51	-0.39	-0.78	0.39	0.53	-0.08	0.09	0.09	0.85	0.3	-0.38	-0.18	0.62	0.23	0.54	0.51	0.44	-0.05	-0.85	0.28		0.38	0.42	0.55
Net Invested Capital	0.99	0.61	-0.41	-0.75	0.95	0.93	0.85	0.88	0.54	0.77	0.4	0.52	0.69	0.95	0.52	0.97	0.91	0.84	-0.57	-0.33	0.74	0.38		0.92	0.97
Net Working Capital	0.91	0.57	-0.62	-0.77	0.84	0.96	0.66	0.74	0.53	0.73	0.38	0.5	0.5	0.91	0.38	0.91	0.95	0.87	-0.61	-0.41	0.86	0.42	0.92		0.94
Capital Stock	0.97	0.61	-0.45	-0.87	0.94	0.96	0.73	0.82	0.56	0.86	0.42	0.42	0.5	0.98	0.54	0.97	0.95	0.88	-0.56	-0.45	0.75	0.55	0.97	0.94

Click cells to compare fundamentals

About BioLife Solutions Financial Statements

BioLife Solutions shareholders use historical fundamental indicators, such as Capital Stock, to determine how well the company is positioned to perform in the future. Although BioLife Solutions investors may analyze each financial statement separately, they are all interrelated. The changes in BioLife Solutions' assets and liabilities, for example, are also reflected in the revenues and expenses on on BioLife Solutions' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

		Last Reported	Projected for Next Year
	Capital Stock	47 K	39.3 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for BioLife Stock Analysis

When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

BioLife Capital Stock from 2010 to 2025

Latest BioLife Solutions' Capital Stock Growth Pattern

BioLife Capital Stock Regression Statistics

BioLife Capital Stock History

Other Fundumenentals of BioLife Solutions

BioLife Solutions Capital Stock component correlations

About BioLife Solutions Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for BioLife Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY